2-[4-(2-amino-4-pyridinyl)-3,5-dimethylpyrazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-[3,5-dimethyl-4-(2-methyl-4-pyridinyl)pyrazol-1-yl]-N-(3-isocyano-5-pyrazin-2-yl-2-pyridinyl)acetamide;2-[3,5-dimethyl-4-[6-methyl-2-(trifluoromethyl)pyrimidin-4-yl]pyrazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-[3,5-dimethyl-4-[2-(trifluoromethyl)-4-pyridinyl]pyrazol-1-yl]-N-(3-fluoro-5-pyrazin-2-yl-2-pyridinyl)acetamide;bis(2-[3,5-dimethyl-4-[2-(trifluoromethyl)-4-pyridinyl]pyrazol-1-yl]-N-(3-methyl-5-pyrazin-2-yl-2-pyridinyl)acetamide);2-[3-methyl-4-(2-methyl-4-pyridinyl)pyrazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-[3-methyl-4-(2-methyl-4-pyridinyl)pyrazol-1-yl]-N-(5-pyrimidin-5-yl-2-pyridinyl)acetamide
C176H154F13N59O8 — CID 158331342
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[4-(2-amino-4-pyridinyl)-3,5-dimethylpyrazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-[3,5-dimethyl-4-(2-methyl-4-pyridinyl)pyrazol-1-yl]-N-(3-isocyano-5-pyrazin-2-yl-2-pyridinyl)acetamide;2-[3,5-dimethyl-4-[6-methyl-2-(trifluoromethyl)pyrimidin-4-yl]pyrazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-[3,5-dimethyl-4-[2-(trifluoromethyl)-4-pyridinyl]pyrazol-1-yl]-N-(3-fluoro-5-pyrazin-2-yl-2-pyridinyl)acetamide;bis(2-[3,5-dimethyl-4-[2-(trifluoromethyl)-4-pyridinyl]pyrazol-1-yl]-N-(3-methyl-5-pyrazin-2-yl-2-pyridinyl)acetamide);2-[3-methyl-4-(2-methyl-4-pyridinyl)pyrazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-[3-methyl-4-(2-methyl-4-pyridinyl)pyrazol-1-yl]-N-(5-pyrimidin-5-yl-2-pyridinyl)acetamide
2-[4-(2-amino-4-pyridinyl)-3,5-dimethylpyrazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-[3,5-dimethyl-4-(2-methyl-4-pyridinyl)pyrazol-1-yl]-N-(3-isocyano-5-pyrazin-2-yl-2-pyridinyl)acetamide;2-[3,5-dimethyl-4-[6-methyl-2-(trifluoromethyl)pyrimidin-4-yl]pyrazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-[3,5-dimethyl-4-[2-(trifluoromethyl)-4-pyridinyl]pyrazol-1-yl]-N-(3-fluoro-5-pyrazin-2-yl-2-pyridinyl)acetamide;bis(2-[3,5-dimethyl-4-[2-(trifluoromethyl)-4-pyridinyl]pyrazol-1-yl]-N-(3-methyl-5-pyrazin-2-yl-2-pyridinyl)acetamide);2-[3-methyl-4-(2-methyl-4-pyridinyl)pyrazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-[3-methyl-4-(2-methyl-4-pyridinyl)pyrazol-1-yl]-N-(5-pyrimidin-5-yl-2-pyridinyl)acetamide (PubChem CID 158331342) has the molecular formula C176H154F13N59O8 and a molecular weight of 3470.55 g/mol. Its IUPAC name is 2-[4-(2-amino-4-pyridinyl)-3,5-dimethylpyrazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-[3,5-dimethyl-4-(2-methyl-4-pyridinyl)pyrazol-1-yl]-N-(3-isocyano-5-pyrazin-2-yl-2-pyridinyl)acetamide;2-[3,5-dimethyl-4-[6-methyl-2-(trifluoromethyl)pyrimidin-4-yl]pyrazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-[3,5-dimethyl-4-[2-(trifluoromethyl)-4-pyridinyl]pyrazol-1-yl]-N-(3-fluoro-5-pyrazin-2-yl-2-pyridinyl)acetamide;bis(2-[3,5-dimethyl-4-[2-(trifluoromethyl)-4-pyridinyl]pyrazol-1-yl]-N-(3-methyl-5-pyrazin-2-yl-2-pyridinyl)acetamide);2-[3-methyl-4-(2-methyl-4-pyridinyl)pyrazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-[3-methyl-4-(2-methyl-4-pyridinyl)pyrazol-1-yl]-N-(5-pyrimidin-5-yl-2-pyridinyl)acetamide.
Molecular Properties
| Compound Name | 2-[4-(2-amino-4-pyridinyl)-3,5-dimethylpyrazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-[3,5-dimethyl-4-(2-methyl-4-pyridinyl)pyrazol-1-yl]-N-(3-isocyano-5-pyrazin-2-yl-2-pyridinyl)acetamide;2-[3,5-dimethyl-4-[6-methyl-2-(trifluoromethyl)pyrimidin-4-yl]pyrazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-[3,5-dimethyl-4-[2-(trifluoromethyl)-4-pyridinyl]pyrazol-1-yl]-N-(3-fluoro-5-pyrazin-2-yl-2-pyridinyl)acetamide;bis(2-[3,5-dimethyl-4-[2-(trifluoromethyl)-4-pyridinyl]pyrazol-1-yl]-N-(3-methyl-5-pyrazin-2-yl-2-pyridinyl)acetamide);2-[3-methyl-4-(2-methyl-4-pyridinyl)pyrazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-[3-methyl-4-(2-methyl-4-pyridinyl)pyrazol-1-yl]-N-(5-pyrimidin-5-yl-2-pyridinyl)acetamide |
|---|---|
| PubChem CID | 158331342 |
| Molecular Formula | C176H154F13N59O8 |
| Molecular Weight | 3470.55 g/mol |
| Exact Mass | 3468.32 |
| IUPAC Name | 2-[4-(2-amino-4-pyridinyl)-3,5-dimethylpyrazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-[3,5-dimethyl-4-(2-methyl-4-pyridinyl)pyrazol-1-yl]-N-(3-isocyano-5-pyrazin-2-yl-2-pyridinyl)acetamide;2-[3,5-dimethyl-4-[6-methyl-2-(trifluoromethyl)pyrimidin-4-yl]pyrazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-[3,5-dimethyl-4-[2-(trifluoromethyl)-4-pyridinyl]pyrazol-1-yl]-N-(3-fluoro-5-pyrazin-2-yl-2-pyridinyl)acetamide;bis(2-[3,5-dimethyl-4-[2-(trifluoromethyl)-4-pyridinyl]pyrazol-1-yl]-N-(3-methyl-5-pyrazin-2-yl-2-pyridinyl)acetamide);2-[3-methyl-4-(2-methyl-4-pyridinyl)pyrazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-[3-methyl-4-(2-methyl-4-pyridinyl)pyrazol-1-yl]-N-(5-pyrimidin-5-yl-2-pyridinyl)acetamide |
| SMILES | Cc1cc(-c2c(C)nn(CC(=O)Nc3ccc(-c4cnccn4)cn3)c2C)nc(C(F)(F)F)n1.Cc1cc(-c2cn(CC(=O)Nc3ccc(-c4cnccn4)cn3)nc2C)ccn1.Cc1cc(-c2cn(CC(=O)Nc3ccc(-c4cncnc4)cn3)nc2C)ccn1.Cc1cc(-c2cnccn2)cnc1NC(=O)Cn1nc(C)c(-c2ccnc(C(F)(F)F)c2)c1C.Cc1cc(-c2cnccn2)cnc1NC(=O)Cn1nc(C)c(-c2ccnc(C(F)(F)F)c2)c1C.Cc1nn(CC(=O)Nc2ccc(-c3cnccn3)cn2)c(C)c1-c1ccnc(N)c1.Cc1nn(CC(=O)Nc2ncc(-c3cnccn3)cc2F)c(C)c1-c1ccnc(C(F)(F)F)c1.[C-]#[N+]c1cc(-c2cnccn2)cnc1NC(=O)Cn1nc(C)c(-c2ccnc(C)c2)c1C |
| InChI | InChI=1S/2C23H20F3N7O.C23H20N8O.C22H17F4N7O.C22H19F3N8O.C21H20N8O.2C21H19N7O/c2*1-13-8-17(18-11-27-6-7-28-18)10-30-22(13)31-20(34)12-33-15(3)21(14(2)32-33)16-4-5-29-19(9-16)23(24,25)26;1-14-9-17(5-6-26-14)22-15(2)30-31(16(22)3)13-21(32)29-23-19(24-4)10-18(11-28-23)20-12-25-7-8-27-20;1-12-20(14-3-4-29-18(8-14)22(24,25)26)13(2)33(32-12)11-19(34)31-21-16(23)7-15(9-30-21)17-10-27-5-6-28-17;1-12-8-16(30-21(29-12)22(23,24)25)20-13(2)32-33(14(20)3)11-19(34)31-18-5-4-15(9-28-18)17-10-26-6-7-27-17;1-13-21(15-5-6-25-18(22)9-15)14(2)29(28-13)12-20(30)27-19-4-3-16(10-26-19)17-11-23-7-8-24-17;1-14-7-16(5-6-24-14)19-11-28(27-15(19)2)12-21(29)26-20-4-3-17(10-25-20)18-8-22-13-23-9-18;1-14-9-16(5-6-23-14)18-12-28(27-15(18)2)13-21(29)26-20-4-3-17(10-25-20)19-11-22-7-8-24-19/h2*4-11H,12H2,1-3H3,(H,30,31,34);5-12H,13H2,1-3H3,(H,28,29,32);3-10H,11H2,1-2H3,(H,30,31,34);4-10H,11H2,1-3H3,(H,28,31,34);3-11H,12H2,1-2H3,(H2,22,25)(H,26,27,30);3-11,13H,12H2,1-2H3,(H,25,26,29);3-12H,13H2,1-2H3,(H,25,26,29) |
| InChIKey | GQAWWHSKRAGWNL-UHFFFAOYSA-N |
| XLogP | 29.40 |
| TPSA | 831.11 Ų |
| H-Bond Donors | 9 |
| H-Bond Acceptors | 58 |
| Rotatable Bonds | 40 |
| Heavy Atoms | 256 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 3470.55 |
| LogP ≤ 5 | 29.40 |
| H-Bond Donors ≤ 5 | 9 |
| H-Bond Acceptors ≤ 10 | 58 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158331342 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.